Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
MannKind Corp. (NASDAQ:MNKD): This development stage biopharmaceutical company saw great insider interest. The company CEO and Chairman Alfred E Mann bought 40 million shares at the average purchase price of $2.59. The entire transaction was worth $103.6 million.
MannKind is currently trading at $2.21, up 1.38 percent from its previous close of $2.18. It has traded in the range of $1.57 and $3.48 in the past 52 weeks. However, the stock is trading below its 20 days moving average price of $2.22 and 50 days moving average price of $2.23. Mannkind is currently involved in developing Afrezza, an insulin therapy for treating adults with Type 1 and Type 2 diabetes. The company is based out of California. Mannkind is trading at beta of 0.54 and it reported its latest EPS at -$1.02.
Liberty Media Corp. (NASDAQ:LMCA): The company chairman John C Malone bout 490,597 shares of Liberty Media Corp. for $115 apiece. The total transaction amounted to $56.418 million. There had been total 31 insider trading transactions in the past three months. Out of which 11 were buy transactions. The stock is trading at $115.25, up 0.23 percent from its previous close. It has traded in the range of $113.52 and $115.72 in the current trading session. However, the stock is trading above its 20 days moving average price of $115.20 and 50 days moving average price of $115.05. The stock is trading at the Price Earnings ratio of 8.03. Liberty Media is seeking FCC approval for gaining controlling stake in Sirius XM. The company chairman’s buy transaction was accompanied by a number of insider selling transactions carried out by other company executives. Liberty Media is involved in entertainment and communication business. It was earlier known as Liberty CapStarz Inc. and it changed the name in September 2011.
Team Inc. (NYSE:TISI): The stock is currently trading at $36.96, down 0.14 percent from its previous close. However, its CEO Philip J Hawk, bought 155,160 shares for $5.894 million at the average price of $37.99. In last three months, the stock has seen net selling of 237,041 shares. There were 7 buy transactions and 18 sell transactions. Team Inc. has traded in the range of $24.95 and $39.05 in the past 52 weeks. Its Price Earnings ratio is 22.73 and the stock’s beta is 1.43. Team Inc. stock was recently downgraded by KeyBanc Capital Markets from Buy to Hold. The company offers its services to heavy industries. It specializes in providing construction and maintenance services for high pressure and high temperature piping systems. Team Inc. is based out of Alvin in Texas and it was formed in 1973. It is mainly active in the United States, Canada and Europe.
WR Berkley Corp. (NYSE:WRB): Clement P Patafio, the company Vice President, bought 63,570 shares at $39.33 each. The total transaction amounted to $2.5 million. The company recently reported that it suffered $50 million worth of loss due to Sandy Storm. WR Berkley Corp. acts as a commercial line insurance writer. It has divided its business into five main categories including specialty, regional, international, reinsurance and alternative markets. WR Berkley Corp. operates in about 40 countries and it is based out of Connecticut. WR Berkley Corp. is currently trading at $38.64, down 0.05 percent from its previous close. It has traded in the range of $33.34 and $40.39 in the past 52 weeks. However, the stock is trading above its 20 days moving average price of $38.62 and 50 days moving average price of $38.58. The stock is trading at the Price Earnings ratio of 11.93.
Santarus Inc. (NASDAQ:SNTS): The stock is currently trading at $10.95, down 2.23 percent from its previous close. It has traded in the range of $10.92 and $11.30 in current session. Its director Ted W Love bought $2.012 million worth of shares. The transaction consisted of 185,000 shares at $10.88 each. The stock is trading below its 20 days moving average price of $11.02 and 50 days moving average price of $11.06. The stock is trading at the beta of 1.29 and its Price Earnings ratio is 49.96. Santarus Inc. is a biopharmaceutical company. It is involved in the business of developing and marketing of medical therapies. Santarus Inc. is based out of San Diego in California and it was formed in 1996.
